Skip to content

Schrodinger SDGR Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$18.45M+30.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$3.53M-2.5%
Revvity logo
RevvityRVTY
-$74.69M-115%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$4.12M-40.6%
PDF Solutions logo
PDF SolutionsPDFS
$1.49M-62.0%
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
-$4.07M-283%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's change in accrued liabilities?
Schrodinger (SDGR) reported change in accrued liabilities of -$14.49M in Q1 2026.
How has Schrodinger's change in accrued liabilities changed year-over-year?
Schrodinger's change in accrued liabilities increased by 29.7% year-over-year, from -$20.62M to -$14.49M.
What is the long-term trend for Schrodinger's change in accrued liabilities?
Over 3 years (2021 to 2024), Schrodinger's change in accrued liabilities has grown at a 17.3% compound annual growth rate (CAGR), from $6.41M to $10.35M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.